VHCP Management as of Sept. 30, 2015
Portfolio Holdings for VHCP Management
VHCP Management holds 18 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anacor Pharmaceuticals In | 35.1 | $139M | 1.2M | 117.71 | |
| Dbv Technologies (DBVTF) | 12.0 | $48M | 694k | 68.54 | |
| Gw Pharmaceuticals Plc ads | 7.2 | $29M | 312k | 91.37 | |
| Heron Therapeutics (HRTX) | 6.8 | $27M | 1.1M | 24.40 | |
| Regenxbio Inc equity us cm (RGNX) | 6.0 | $24M | 1.1M | 22.04 | |
| Coherus Biosciences (CHRS) | 4.4 | $17M | 870k | 20.04 | |
| Zafgen | 4.4 | $17M | 542k | 31.95 | |
| Lipocine | 3.8 | $15M | 1.3M | 11.83 | |
| Ascendis Pharma A S (ASND) | 3.6 | $14M | 811k | 17.70 | |
| Akari Therapeutics | 3.2 | $13M | 528k | 24.00 | |
| Avalanche Biotechnologies In | 2.9 | $11M | 1.4M | 8.24 | |
| Alcobra | 2.3 | $9.1M | 1.5M | 6.04 | |
| Flamel Technologies | 2.1 | $8.2M | 500k | 16.31 | |
| ARCA biopharma | 1.9 | $7.6M | 1.5M | 4.96 | |
| Cynapsus Therapeutics | 1.5 | $5.9M | 367k | 16.17 | |
| Pronai Therapeutics | 1.3 | $5.1M | 250k | 20.52 | |
| D Stemline Therapeutics | 1.0 | $4.0M | 451k | 8.83 | |
| Ocera Therapeutics | 0.6 | $2.2M | 704k | 3.16 |
